Shawn Singh

Affiliations

  • Chief Executive Officer at Vistagen Therapeutics Inc. (VTGN), 2024-07-02
  • Director at Echo Therapeutics Inc. (ECTE), 2010-04-30
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
VTGN $0.17 600,000 $103,200.00 626,234 2022-08-17 Filing